Among those transporters, SLC38A2 or SNAT2 have been reported to be overexpressed in tumors including prostate cancer (65), breast cancer (66), pancreatic cancer (67), and colorectal cancer (68). The gene discussed is SLC38A2; the disease is Familial prostate cancer.